Skip to content

Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation

Incidence and Risk Factors of Acute Postoperative Confusion State After Trans-catheter Aortic Valve Implantation (TAVI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02585128
Enrollment
201
Registered
2015-10-23
Start date
2015-09-30
Completion date
2021-01-31
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Keywords

Delirium, Transcatheter Aortic Valve Implantation, Elderly

Brief summary

Patients undergoing transcatheter aortic valve implantation (TAVI) have distinctive characteristics: they are old, frail, with several co-morbidities and take multiple medications. Hemodynamic instability, cerebral embolism, sedation, general anesthesia and hospitalization in intensive care expose those patients to postprocedural delirium. Acute neurocognitive dysfunctions are associated with adverse outcomes in these population. The objective of this study is to determine the incidence of delirium and neurocognitive disorders in elderly patients after TAVI.

Interventions

During the first post-procedural five days all patients will be evaluated on a daily basis for delirium occurrence by the CAM (Confusion Assessment Method) or CAM - ICU (Confusion Assessment Method - Intensive Care Unit)

OTHERMNA-SF (Mini Nutritional Assessment - Short Form)

Regional cerebral oxygen saturation monitoring during TAVI procedure

OTHERCIRS (Cumulative Illness Rating Scale)

Sponsors

Cardiocentro Ticino
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 65\>years * Patients undergoing transcatheter aortic valve implantation * Patients have given informed consent for participation at the study

Exclusion criteria

* Patient suffering from delirium (CAM diagnosis) at recruitment * Inability to understand the national languages * Emergency procedures

Design outcomes

Primary

MeasureTime frameDescription
Incidence of deliriumDay 1-5 after transcatheter aortic valve implantationThe primary outcome is incidence of delirium. Delirium screening will be carry out using the CAM or CAM-ICU in accordance with local hospital clinical delirium-screening guidelines. The assessment of presence of Delirium will be perform by clinician with CAM in agreement with Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM IV). CAM is standardized method to enable non-psychiatrically trained clinicians to identify delirium and assesses nine features of delirium: (1) acute onset, (2) inattention, (3) disorganized thinking, (4) altered level of consciousness, (5) disorientation, (6) memory impairment, (7) perceptual disturbances, (8) psychomotor agitation or retardation and (9) altered sleep-wake cycle. Delirium is diagnosed when feature 1 and 2 are present and either 3 or 4 are displayed.

Secondary

MeasureTime frameDescription
Risk factors for postoperative deliriumBaseline, intra-operative and days 1-5 after transcatheter aortic valve implantationAssociation between incidence of delirium and patient vulnerabilities, exposure to noxious or precipitating factors. The risk factors will be divided in pre-procedural, intra-procedural and post-procedural
Onset of deliriumDay 1-5 after transcatheter aortic valve implantation
Complications of deliriumDay 1-5 after transcatheter aortic valve implantationComplications delirium related
Trajectories of neurocognitive functionChanges from baseline up to 5 day and 3-monthsChange of Mini-Mental State Examination (MMSE)
Trajectories of functional abilitiesChanges from baseline up to 5 day and 3-monthsChange of Barthel Index (for Activities of Daily Living, ADL)
Mortality30-days, 3-months and 1 yearPostoperative survival
Type of deliriumDay 1-5 after transcatheter aortic valve implantationDelirium classification according to Delirium Motor Subtype Scale (DMSS-4)

Other

MeasureTime frameDescription
TAVI complicationsParticipants will be followed for the first 72-96 hours after TAVIComplications according to VARC-2 (Valve Academic Research Consortium -2)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026